Boothbay Fund Management, LLC Avid Bioservices, Inc. Transaction History

Boothbay Fund Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$6.34 - $9.28 $1.54 Million - $2.25 Million	-242,633 Reduced 62.97%	142,675 $1.02 Million
Q1 2024 May 15, 2024	BUY	$5.86 - $8.79 $577,321 - $865,982	98,519 Added 34.35%	385,308 $2.58 Million
Q4 2023 Feb 14, 2024	BUY	$4.64 - $9.56 $1.08 Million - $2.23 Million	233,286 Added 436.02%	286,789 $1.86 Million
Q3 2023 Nov 14, 2023	BUY	$9.4 - $14.04 $155,165 - $231,758	16,507 Added 44.62%	53,503 $505,000
Q2 2023 Aug 14, 2023	BUY	$12.96 - $20.93 $479,468 - $774,326	36,996 New	36,996 $516,000

183

67.8M

89.9K

118K

Ticker CDMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,167,500
Market Cap $765M
Description
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.